Page last updated: 2024-12-05

dimethyldithiocarbamate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

Dimethyldithiocarbamate: A chemical that acts as a dopamine beta-hydroxylase inhibitor. Its salts are agricultural fungicides. It is inferior to diethyldithiocarbamate as a chelating agent. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

dimethyldithiocarbamate : A member of the class of dithiocarbamate anions resulting from the removal of the proton from the dithiocarbamic acid moiety of dimethyldithiocarbamic acid. The major species at pH 7.3. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID3566770
CHEBI ID84293
MeSH IDM0006461

Synonyms (21)

Synonym
BIDD:ER0360
dimethyldithiocarbamate
NCGC00164536-01
n,n-dimethylcarbamodithioate
A807233
NCGC00164536-02
NCGC00164536-03
NCGC00164536-06
NCGC00164536-04
NCGC00164536-05
BBL012267
STL163585
dimethylcarbamodithioate
bdbm50382712
AKOS005716462
dimethyldithiocarbamic acid anion
CHEBI:84293
dimethyldithiocarbamic acid(1-)
Q27157659
thiram tp
n,n dimethyl carbamosulfonic acid

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Ferbam and thiram were more toxic on the basis of weight than zineb; maneb was relatively nontoxic."( Oral toxicity of ferric dimethyl-dithiocarbamate (ferbam) and tetramethylthiuram disulfide (thiram) in rodents.
Lee, CC; Minor, JL; Russell, JQ, 1978
)
0.26
"We previously determined that the dithiocarbamate pesticide sodium metam (NaM) and its active ingredient methylisothiocyanate (MITC) were developmentally toxic causing notochord distortions in the zebrafish."( Dithiocarbamates have a common toxic effect on zebrafish body axis formation.
Alzarban, N; La Du, JK; Tanguay, RL; Tilton, F; Vue, M, 2006
)
0.33
" CDDC was shown to be toxic to the livers and kidneys, at all doses used, and this toxicity is related to peroxidative insult."( Toxicity and bioaccumulation of the wood preservative copper dimethyldithiocarbamate in tissues of Long-Evans rats.
Scharf, B; Trombetta, LD, 2008
)
0.35

Dosage Studied

ExcerptRelevanceReference
" Urinary excretion of radioactivity, following dosing with DMDTC and exposure to 200 ppm C-14 butadiene for 6 h, was markedly reduced in rats, but increased in mice."( The influence of co-exposure to dimethyldithiocarbamate on butadiene metabolism.
Green, T; Moore, R; Toghill, A, 2001
)
0.31
" Sprague-Dawley rats were gavaged for 14 days with DBA (0-150mg/kg) and ovariectomized on dosing day 11, and at the same time implanted with an estradiol capsule to generate daily LH surges."( Moderating influence of the drinking water disinfection by-product dibromoacetic acid on a dithiocarbamate-induced suppression of the luteinizing hormone surge in female rats.
Buckalew, AR; Cooper, RL; Ferrell, JM; Goldman, JM; Murr, AS, 2007
)
0.34
" The yield of nitrosamines increased with the oxidant dosage for both monochloramination and ozonation of DTCs."( Oxidation of dithiocarbamates to yield N-nitrosamines by water disinfection oxidants.
Huang, CH; Kim, JH; Padhye, LP, 2013
)
0.39
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
dithiocarbamate anionsAny organic sulfur anion resulting from the removal of a proton from any N-substituted dithiocarbamic acid.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (113)

TimeframeStudies, This Drug (%)All Drugs %
pre-199044 (38.94)18.7374
1990's12 (10.62)18.2507
2000's30 (26.55)29.6817
2010's15 (13.27)24.3611
2020's12 (10.62)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (1.56%)6.00%
Case Studies1 (0.78%)4.05%
Observational0 (0.00%)0.25%
Other125 (97.66%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]